Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their verbal agreement to take part in the study
- People who have been diagnosed with a major sickle cell syndrome, of any genetic type (for example, SS, SC, or Sbeta)
- People who have a strong enough understanding of spoken and written French to complete questionnaires, follow the program sessions, and do the home exercises
Who may not be able to join:
- People who have one or more serious psychiatric conditions (such as severe depression or psychosis) that could affect the study results
- People who have another long-term illness that causes fatigue
- People who are currently experiencing a vaso-occlusive crisis (a painful sickle cell episode) or who are currently hospitalised
- People who are under a legal protection order (such as guardianship or curatorship) or who are deprived of their liberty
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie-Claire GAY, Pr, Paris Nanterre University
Phone: 0139638856
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of the FACETS program for adult sickle-cell patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.